Alzheimer Disease

In a small clinical trial, researchers found that patients taking suvorexant, an FDA-approved treatment for insomnia, had reduced levels of amyloid beta (amyloid-β) and tau phosphorylation proteins, which...

In this podcast, Sri Banerjee, MD, PhD, MPH, MAS, discusses the impact of diabetes on Alzheimer disease-related dementia mortality among Black Americans, including the burden and pathophysiology of...

In this video, Madhav Thambisetty, MD, discusses a new treatment for patients with Alzheimer disease, lecanemab, recently approved by the FDA, including the presumed mechanism of action, benefits, risks,...

In this interview, Emile d’Angremont, MSc, discusses the results of a recent study examining the use of cholinesterase inhibitors for the management of psychotic symptoms among patients with...

In this video, Gillian T. Coughlan, MS, PhD discusses her team's study results, which found that female sex, early-age menopause, and hormone therapy use beginning more than 5 years after menopause were...

In this podcast episode, Lisa Jones, interviews Amylee Amos, PhD, RDN, IFMCP, about the key arguments and controversies surrounding specific diets in relation to Alzheimer disease prevention and management,...

In this video, Paul Schulz, MD, discusses the next steps for research on the relationship between infection and Alzheimer disease. This is part three in a three-part series.

In this video, Paul Schulz, MD, discusses the relationship between infection and Alzheimer disease risk and what health care practitioners can recommend to patients to reduce their risk for Alzheimer...

In this video, Paul Schulz, MD, discusses the results of his team's latest study examining the impact of various routine vaccinations on Alzheimer disease risk in individuals 65 years of age or older. ...

In this podcast episode, Lisa Jones, interviews Amylee Amos, PhD, RDN, IFMCP, about the practical and actionable nutrition strategies that dietitians can recommend to individuals managing Alzheimer disease...